Heron Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of HRTX for the last quarter is 32.81 M USD, and it's 8.92% lower compared to the previous quarter. The net income of Q3 24 is -4.85 M USD.